Effect of COVID-19 on the Treatment of Infections by Community Pharmacists in Nigeria
Abstract
COVID-19 has had tremendous effects on different aspects of health care. Patients have been one of the most affected since the pandemic has limited their access to healthcare everywhere in the world including Nigeria. Reduced access to healthcare services in hospitals has caused an increase in the number of patient visits to the community pharmacies. This study was designed to evaluate the effect of the COVID-19 pandemic on the treatment of infections by community pharmacists. This study was a prospective cross-sectional study that was carried out among community pharmacists working in community pharmacies in Ibadan, Oyo state and Uyo, Akwa Ibom state due to the recent rise in COVID-19 cases from July until August 2020. Data was collected through a pre-tested online questionnaire which was sent to the pharmacists upon provision of consent after the purpose of the study was explained. A total of one hundred and twenty two pharmacists consented to participate in this study out of which 65 (53.3%) were female. Malaria (81, 66.4%), respiratory tract infections (40, 32.8%) and sexually transmitted infections (1, 0.8%) were identified as infections with the highest frequency by the community pharmacists, while more than 96% (118) pharmacists reported that COVID-19 has affected the way they manage or treat other infections seen in their pharmacy. This study shows that the COVID-19 pandemic has affected the way community pharmacists treat other infections in the community pharmacy setting. More studies are needed to explore the specific nature of this effect on specific infections.
Keywords
Full Text:
PDFReferences
World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 51. Available at: https://apps.who.int/iris/handle/10665/331475 (Accessed on June22, 2020)
Singh A, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis, and practical considerations. Diabetes and Metabolic Syndrome Clinical Research and Review. 2020;14(4):303–310
Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine. 2020; 25:1–8.
Rossi R, Socci V, Pacitti F, Di Lorenzo G, Di Marco A, Siracusano A, Rossi A. Mental Health Outcomes Among Frontline and Second-Line Health Care Workers During the Coronavirus Disease 2019 (COVID-19) Pandemic in Italy. JAMA Network Open 2020; 3(20):10185
Varshney M, Parel J, Raizada N, Sarin S. Initial psychological impact of COVID-19 and its correlates in Indian Community: An online (FEEL-COVID) survey. PLoS ONE 2020; 15(23):3874.
Talevi D, Socci V, Carai M, Carnaghi G, Faleri S, Trebbi E, Bernardo A, Capelli F, Pacitti F. Mental health outcomes of the CoVID-19 pandemic. Rivista di Psichiatria 2020; 55: 137–144.
Khetrapal S, Bhatia R. Impact of COVID-19 pandemic on healthcare system and sustainable Development Goal. Indian Journal of Medical Research 2020; 202(151):395-399
Shadmi E, Chen Y, Dourado I, Faran-Perach I, Furler J, Hangoma P, Hanvoravongchai P, Obando C, Petrosyan V, Rao KD, Ruano AL, Shi L, de Souza LE, Spitzer-Shohat S, Sturgiss E, Suphanchaimat R, Uribe MV, Willems S. Health equity and COVID-19: global perspectives. International Journal of Equity Health. 2020;19(1):104.
Tsuyuki R, Beahm N, Okada H, Al Hamarneh Y. Pharmacists as accessible primary health care providers: Review of the evidence. Canadian Pharmacy Journal. 2018; 151(1):4-5.
Hedima E, Adeyemi M, Ikunaiye N. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs. Research in Social and Administrative Pharmacy 2020; 17(20):30385.
Grant M, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke E. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE 2020; 15(6): 234765.
General Assembly of the World Medical Association. 2014 World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Journal of the American College of Dentists 2020; 310(20): 2191-2194
Nigeria Center for Disease Control. Epicurve by state 2020. Available at: https://covid19.ncdc.gov.ng/state/ (Accessed on June 20, 2020)
Uyo | Location, Facts, & Population | Britannica. Available at: https://www.britannica.com/place/Uyo (Accessed June 20, 2020)
Local Governments in Ibadan. Available at: www.ibadanlanda.org/Local_Government.html (Accessed June 20, 2020)
Brian O, Henry N. Community pharmacists and health promotion activities in the 21st century; maximizing the expanded roles for universal health coverage and population health optimization. MedCrave Online Journal of Public Health. 2017;6(3):354‒358.
Chenneville T, Gabbidon K, Hanson P, Holyfield C. The Impact of COVID-19 on HIV Treatment and Research: A Call to Action. International Journal of Environmental Research and Public Health 2020; 17(12):4548.
Verroken A, Scohy A, Gérard L, Wittebole X, Collienne C, Laterre P. Co-infections in COVID-19 critically ill and antibiotic management: A prospective cohort analysis. Critical Care 2020; 24(1): 410.
Benmalek R, Mechal H, Choukrallah H, Maaroufi A, Benouna E, Habbal R, Aissaoui O, Erragh A, Nssiri A, AlHarrar R. Bacterial co-infections and superinfections in COVID-19: A case report of right heart infective endocarditis and literature review. The Pan African Medical Journal 2020; 35(2): 40
Al-Quteimat O, Amer A. The Impact of the COVID-19 Pandemic on Cancer Patients. American Journal of Clinical Oncology. 2020;43(6):452-455.
Golemi M, Golemi L, Tafur A, Pursnani A. The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease. Cardiology in Review. 2020; 28(4):163-176.
Hashmi H, Asif H. Early Detection and Assessment of Covid-19. Frontiers in Medicine 2020; 7(311):1-9
Tang Y, Schmitz J, Persing D, Stratton C. Laboratory Diagnosis of COVID-19: Current Issues and Challenges. Journal of Clinical Microbiology 2020; 58(6):512-520
Almazeedi S, Al-Youha S, Jamal M, Al-Haddad M, Al-Muhaini A, Al-Ghimlas F, Al-Sabah S. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinical Medicine 2020; 24 (1000448): 1-9.
Carlucci P, Ahuja T, Petrilli C, Rajagopalan H, Jones S, Rahimian J. Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: Outcomes in hospitalized COVID-19 patients. MedRxiv 2020; 5 (2):1-6
Scholz M, Derwand R, Zelenko V. COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study. Preprints 2020; 7(25): 1-10
DOI: https://doi.org/10.15416/pcpr.v5i3.29262
Refbacks
- There are currently no refbacks.
